Opendata, web and dolomites
H2020 projects about "prophylactic"
The page lists 29 projects related to the topic "prophylactic".
| # | |||
|---|---|---|---|
| 1 | ParaFishControl | Advanced Tools and Research Strategies for Parasite Control in European farmed fish | 2015 |
| 2 | BRIDGES | Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES) | 2015 |
| 3 | DiViNe | Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes | 2015 |
| 4 | EMI-TB | Eliciting Mucosal Immunity to Tuberculosis | 2015 |
| 5 | MACIVIVA | MAnufacturing process for Cold-chain Independent VIrosome-based VAccines | 2015 |
| 6 | Pro-Staph-ID | Clinical biomarker and rapid diagnostic test for Staphylococcus aureus induced ventilator-associated pneumonia | 2014 |
| 7 | ImmunoFarm | IgA-based oral therapy for protection of piglets against infection with enterotoxigenic E. coli. | 2015 |
| 8 | CerviVax | New Generation Therapeutic vaccine for the Treatment of HPV infections and Cervical Dysplasia | 2015 |
| 9 | NEURIMMUNE | Neural regulation of immunity | 2015 |
| 10 | EVAg | European Virus Archive goes global | 2015 |
| 11 | NEMAQUA | Nematodes as the world first pathogen free, ready-to-use and sustainable live feed for larval aquaculture industry | 2015 |
| 12 | EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | 2016 |
| 13 | RABYD-VAX | Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine | 2017 |
| 14 | EBOVAC1 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854 | 2014 |
| 15 | resiliANT | Resilience in ant societies | 2017 |
| 16 | TRANSVAC2 | European Vaccine Research and Development Infrastructure | 2017 |
| 17 | IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer | 2017 |
| 18 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
| 19 | TANWORM | How do tannins kill parasitic worms? | 2019 |
| 20 | EBOVAC3 | Bringing a prophylactic Ebola vaccine to licensure | 2018 |
| 21 | VacPath | Novel vaccine vectors to resist pathogen challenge | 2019 |
| 22 | SWEET CROSSTALK | Training interdisciplinary glycoscientists to get a molecular-level grip on glycocodes at the human mucosa–microbiota interface | 2019 |
| 23 | CRUZIVAX | Vaccine for prevention and treatment of Trypanosoma cruzi infection | 2019 |
| 24 | VASA | Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa | 2019 |
| 25 | NANOELAST | Next-Generation Urinary Catheters for Preventing Catheter Associated Urinary Tract Infections: Emphasis on Antibiotic Resistance | 2019 |
| 26 | BactiVax | anti-Bacterial Innovative Vaccine Training Network. | 2019 |
| 27 | EPIDEMIC | Experimental Epidemiology in Ant Societies | 2020 |
| 28 | PROFID | Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarction | 2020 |
| 29 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |